References
- 1. The MERCK MANUAL TWENTIETH EDITION, 2018.
- 2. Postma DS, Bush A, vsn den Berger M. Risk factors and early origins of chronic obstructive pulmonary disease Lance 2015.10.1016/S0140-6736(14)60446-3
- 3. WHO-Chronic Cor pulmonale Report of an Expert Committee Circulation 1963.
- 4. http://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
- 5. Duvoix A. Dickens J, Imram H., et. Al-Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. T thoarax 2013.
- 6. Fattouh M, Alkady O.- Inflammatory biomarkers in chronic obstructive pulmonary disease, Egyptian Journal of Chest Diseases And Tuberculosis 2014.10.1016/j.ejcdt.2014.06.011
- 7. Bartolome R. C. et al- Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease, Am. Journal Respir. Crit. Care. Med 2012
- 8. Augusti A., Eduards L.D., Rennards S.I., - persistent systemic inflammation is associated with poor clinical outcomes in COPD- Biomarkers in clinical Practice 20121
- 9. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy For The Diagnosis, Management And Preven tion Of Chronic Obstructive-Pulmonary Disease 2021 report.
- 10. RuxandraUlmeanu, Florin DumitruMihaltan, Cristian Oancea – Recomandari de diagnostic sitratament in Bronhopneumopatia Cronica Obstructiva [Diagnosis and Treatment Recommendations for Chronic Obstructive Brocnhopneumopathy], Medicala Publishing House 2019